Streetbeat News

Price Targets

BIIB

Biogen (NASDAQ:BIIB) has received mixed analyst ratings over the last three months, with 10 analysts offering diverse opinions. The average 12-month price target is $308.7, with a high of $373.00 and a low of $239.00, marking a 3.1% decrease from the previous average. Recent actions by analysts include maintaining, raising, and lowering ratings and price targets. Biogen's financials show a revenue growth rate of 0.87%, a net margin of -2.69%, an ROE of -0.47%, an ROA of -0.26%, and a debt-to-equity ratio of 0.53.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 1:00 pm

CYTK

UBS analyst Ashwani Verma downgraded Cytokinetics (NASDAQ:CYTK) from Buy to Neutral but increased the price target from $61 to $92.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:57 pm

DHR

Barclays analyst Luke Sergott has downgraded Danaher (NYSE:DHR) from Overweight to Equal-Weight and set a price target of $240.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:55 pm

TMO

Barclays analyst Luke Sergott has downgraded Thermo Fisher Scientific (TMO) from Overweight to Equal-Weight but increased the price target from $475 to $555.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:54 pm

FHN

UBS analyst Brody Preston has upgraded First Horizon (NYSE:FHN) from Neutral to Buy and increased the price target from $15.5 to $16.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:50 pm

XP

Banco Bradesco BBI S.A analyst Otavio Tanganelli has upgraded XP Inc. (NASDAQ:XP) from Neutral to Outperform and set a price target of $32. This upgrade suggests a positive outlook for XP's stock performance.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:42 pm

STNE

Banco Bradesco BBI S.A analyst Otavio Tanganelli has upgraded StoneCo (NASDAQ:STNE) from Underperform to Neutral and set a price target of $23.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:40 pm

VZ

Raymond James analyst Frank Louthan has maintained an Outperform rating on Verizon Communications (NYSE:VZ) and increased the price target from $42 to $46.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:34 pm

PG

Raymond James analyst Olivia Tong has maintained an Outperform rating on Procter & Gamble (NYSE:PG) and increased the price target from $170 to $175.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:32 pm

PLD

Raymond James analyst William Crow has reaffirmed a Strong Buy rating on Prologis (NYSE:PLD) and increased the price target from $130 to $145, indicating a positive outlook on the stock.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 12:29 pm